Trial Profile
Phase I/II trial of cancer vaccine MUC-1 (ImMucin) in patients with advanced metastatic breast cancer.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 23 Oct 2014
Price :
$35
*
At a glance
- Drugs Cancer vaccine MUC-1 (Primary) ; Antineoplastics
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Vaxil BioTherapeutics
- 23 Oct 2014 New trial record